They Do Look Alike : Mimics of Prostate Cancer in Biopsy Samples

Similar documents
PROSTATIC ADENOCARCINOMA: DIAGNOSTIC CRITERIA AND IMPORTANT MIMICKERS PROSTATIC ADENOCARCINOMA: DIAGNOSTIC CRITERIA

Macro- and microacinar proliferations of the prostate

Pathology of the Prostate. PathoBasic Tatjana Vlajnic

ARTHUR PURDY STOUT SOCIETY COMPANION MEETING: DIFFICULT NEW DIFFERENTIAL DIAGNOSES IN PROSTATE PATHOLOGY. Jonathan I. Epstein.

3/28/2017. Disclosure of Relevant Financial Relationships. GU Evening Subspecialty Case Conference. Differential Diagnosis:

Prostate Pathology: Prostate Carcinoma, variants and Gleason Grading (Part 1)

5/21/2018. Difficulty in Underdiagnosing Prostate Cancer. Diagnosis of Prostate Cancer. Evaluation of Prostate Cancer and Atypical on Needle Biopsy

Gross appearance of nodular hyperplasia in material obtained from suprapubic prostatectomy. Note the multinodular appearance and the admixture of

Synonyms. Nephrogenic metaplasia Mesonephric adenoma

Prostate Biopsy Interpretation: An Illustrated Guide

Although current American Cancer Society guidelines

Dissertation submitted in. Partial fulfilment of the regulations required for the award of M.D. DEGREE PATHOLOGY BRANCH III THE TAMILNADU

PSA. HMCK, p63, Racemase. HMCK, p63, Racemase

ACCME/Disclosures. Cribriform Lesions of the Prostate. Case

Although partial atrophy is one of the most common

Prostate Immunohistochemistry. Literature Interpretation: Caveats. Must be aware of staining pattern of antibody in the relevant tissue

INTRADUCTAL LESIONS OF THE PROSTATE. Jonathan I. Epstein

Prostatic ductal adenocarcinoma is a subtype of

Intraductal carcinoma of the prostate on needle biopsy: histologic features and clinical significance

Diagnosis, pathology and prognosis including variant pathology

Gleason Scoring System 2017 JASREMAN DHILLON, MD ASSOCIATE PROFESSOR, DEPARTMENT OF ANATOMIC PATHOLOGY, MOFFITT CANCER CENTER, TAMPA, FLORIDA

S1.04 Principal clinician. G1.01 Comments. G2.01 *Specimen dimensions (prostate) S2.02 *Seminal vesicles

2016 WHO CLASSIFICATION OF TUMOURS OF THE PROSTATE. Peter A. Humphrey, MD, PhD Yale University School of Medicine New Haven, CT

Breast pathology. 2nd Department of Pathology Semmelweis University

Uropathology January Jon Oxley

Objective. Atypical/Atypia. Atypical Glandular Lesions of the Prostate 12/27/2011

Salivary Glands 3/7/2017

Prostate cancer ~ diagnosis and impact of pathology on prognosis ESMO 2017

5/21/2018. Prostate Adenocarcinoma vs. Urothelial Carcinoma. Common Differential Diagnoses in Urological Pathology. Jonathan I.

Immunohistochemistry in prostate pathology: Recent Advances

6/3/2010. Outline of Talk. Lobular Breast Cancer: Definition of lobular differentiation. Common Problems in Diagnosing LCIS in Core Biopsies

Papillary Lesions of the Breast A Practical Approach to Diagnosis. (Arch Pathol Lab Med. 2016;140: ; doi: /arpa.

Proliferative Epithelial lesions of the Breast. Sami Shousha, MD, FRCPath Charing Cross Hospital & Imperial College, London

Prostate Cancer Grading, Staging and Reporting: An Update Cristina Magi-Galluzzi, MD, PhD

CLINICAL SIGNIFICANCE OF BENIGN EPITHELIAL CHANGES

Grading Prostate Cancer: Recent Changes and Refinements

Muhammad Kashif Baig, Usman Hassan and Samina Mansoor

Department of Diagnostic Pathology, Kochi Red Cross Hospital, Kochi, Japan

CHRONIC PANCREATITIS OR DUCTAL ADENOCARCINOMA? N. Volkan Adsay, \ MD

ISPUB.COM. Interpretation Of Prostatic Biopsies: A Review. A Chitale, S Khubchandani INTRODUCTION NON-NEOPLASTIC LESIONS GRADING: GLEASON'S SCORE

Papillary Lesions of the breast

Urinary Bladder: WHO Classification and AJCC Staging Update 2017

1 NORMAL HISTOLOGY AND METAPLASIAS

B asal cell proliferations in the prostate gland exhibit a

Disclosures 5/27/2012. Outline of Talk. Outline of Talk. When Is LCIS Clinically Significant? Classic LCIS. Classic LCIS

Update in Salivary Gland Pathology. Benjamin L. Witt University of Utah/ARUP Laboratories February 9, 2016

Updates in Urologic Pathology WHO Made Those Changes?! Peyman Tavassoli Pathology Department BC Cancer Agency

Minimal Adenocarcinoma in Prostate Needle Biopsy Tissue

Protocol for the Examination of Specimens From Patients With Carcinoma of the Prostate Gland

Outline (1) Outline (2) Concepts in Prostate Pathology. Peculiarities of Prostate Cancer. Peculiarities of Prostate Cancer

Update on Reporting Prostate Cancer Pathology

Basement membrane in lobule.

Enterprise Interest None

Condyloma Acuminatum. Mimics of Bladder Cancer. Squamous Papilloma. Squamous epithelium in bladder

04/10/2018. Intraductal Papillary Neoplasms Of Breast INTRADUCTAL PAPILLOMA

Ductal Carcinoma in Situ. Laura C. Collins, M.D. Department of Pathology Beth Israel Deaconess Medical Center and Harvard Medical School Boston, MA

Supplemental Figure 1

3/23/2017. Significant Changes in Prostate Cancer Classification, Grading, Staging and Reporting. Disclosure of Relevant Financial Relationships

Incidence of ductal lesions

Case #1: 75 y/o Male (treated and followed by prostate cancer oncology specialist ).

GOBLET CELL CARCINOID. Hanlin L. Wang, MD, PhD University of California Los Angeles

GOBLET CELL CARCINOID

Diagnostically Challenging Cases in Gynecologic Pathology

LYMPHATIC DRAINAGE AXILLARY (MOSTLY) INTERNAL MAMMARY SUPRACLAVICULAR

Some prostatic diseases

Surgical Pathology Issues of Practical Importance

Pancreatitis: A Potential Pitfall in Endoscopic Ultrasound Guided Pancreatic FNA

Salivary Gland Cytology

CASE REPORT Malignant transformation of breast ductal adenoma: a diagnostic pitfall

Clinicopathological Study of Associated Lesions in Benign Prostatic Hyperplasia and Prostatic Adenocarcinoma in Surgical Biopsy Specimens

The pathology of unusual subtypes of prostate cancer

5/2/2018. Low Grade Dysplasia of GI Tract. High Grade Dysplasia of GI Tract. Dysplasia in Gastrointestinal Tract: Practical Pearls and Issues

Oncocytic-Appearing Salivary Gland Tumors. Oncocytic, Cystic, Mucinous, and High Grade Salivary Gland Tumors SALIVARY GLAND FNA: PART II

Metachronous anterior urethral metastasis of prostatic ductal adenocarcinoma

Differential Diagnosis of Oral Masses. Palatal Lesions

Kidney, Bladder and Prostate Neoplasia. David Bingham MD

Coordinate Expression of Cytokeratins 7 and 20 in Prostate Adenocarcinoma and Bladder Urothelial Carcinoma

6/5/2010. Outline of Talk. Endometrial Alterations That Mimic Cancer & Vice Versa: Metaplastic / reactive changes. Problems in Biopsies/Curettages

USE OF IMMUNOHISTOCHEMISTRY AS AN ADJUNCT IN THE DIAGNOSIS OF LIMITED ADENOCARCINOMA OF THE PROSTATE CANCER. Jonathan Epstein

Carcinoma mammario: le istologie non frequenti. Valentina Guarneri Università di Padova IOV-IRCCS

Protocol for the Examination of Biopsy Specimens From Patients With Carcinoma of the Prostate Gland

Columnar Cell Lesions. Columnar Cell Lesions and Flat Epithelial Atypia

S1.04 PRINCIPAL CLINICIAN G1.01 COMMENTS S2.01 SPECIMEN LABELLED AS G2.01 *SPECIMEN DIMENSIONS (PROSTATE) S2.03 *SEMINAL VESICLES

Benign Breast Disease and Breast Cancer Risk

Rare prostate tumors: beyond adenocarcinoma

Ductal Proliferations of the Breast: The Good, the Bad, and the Ugly

Review of the AP Part II Practical Examination. Dr David Clift Co Chief Examiner

Objectives. Atypical Glandular Cells. Atypical Endocervical Cells. Reactive Endocervical Cells

Science & Technologies ATYPICAL NEPHROGENIC METAPLASIA OF THE URINARY BLADDER: A CASE REPORT AND REVIEW OF THE LITERATURE

Columnar Cell Lesions

Dr Sanjiv Manek Oxford. Oxford Pathology Course 2010 for FRCPath Illustration-Cellular Pathology. Oxford Radcliffe NHS Trust

Pitfalls in thyroid tumor pathology. Prof.Valdi Pešutić-Pisac MD, PhD

Case: The patient is a 62 year old woman with a history of renal cell carcinoma that was removed years ago. A 2.4 cm liver mass was found on CT

Immunohistochemistry and Bladder Tumours

Atypical Hyperplasia/EIN

Lesion Imaging Characteristics Mass, Favoring Benign Circumscribed Margins Intramammary Lymph Node

New Diagnoses Need New Approaches: A Glimpse into the Near Future of Gynecologic Pathology

Select problems in cystic pancreatic lesions

Prostate cancer grading: a decade after the 2005 modified system

Salivary gland neoplasms: an update 29th Annual Meeting of Arab Division of the International Academy of Pathology MUSCAT, OMAN 2017

Transcription:

They Do Look Alike : in Biopsy Samples Gladell P. Paner, MD Departments of Pathology and Surgery (Urology) University of Chicago, IL USA Gladell.paner@uchospitals.edu

Benign in Needle Biopsy 1. Benign crowded glands 2. Atrophy simple, post atrophic hyperplasia, partial 3. Hyperplasia usual, atypical adenomatous (adenosis), clear cell cribriform, basal cell, sclerosing adenosis More important classification whether its CANCER or NOT! 4. Metaplasia nephrogenic, mucinous 5. Reactive atypia inflammatory, post-therapy, ischemic 6. Inflammation prostatitis, xanthoma, nonspecific granulomatous, malakoplakia 7. Artifacts crushed glands, rectal tissue 8. Histoanatomic structures - a. Prostatic (PSA+) - cribriform central zone gland, verumontanum mucosal gland b. Non-prostatic (PSA-) - Mesonephric remnants, Cowper s gland, seminal vesicles, ejaculatory duct, paraganglion Srigley J. Mod Pathol. 2004;17:328. Trpkov K. Mod Pathol. 2018;31:S22. 2

Benign in Needle Biopsy Important to know what exactly the benign mimic - MIMICS 3

Which Cancer Patterns Are Mimicked? 1. Gleason architecture Majority (well-formed gland) Hyperplasia (cribriform), xanthoma, paraganglion (fused) Inflammation (infiltrative, solid) Am J Surg Pathol 2016;40:244 2. Carcinoma variants atrophic (atrophy), pseudohyplastic and microcystic (hyperplasia), foamy gland (xanthoma), pleomorphic giant cell (seminal vesicle/ejaculatory duct), mucinous (metaplasia), signet ring cell (inflammation) 4

Well-formed glands (GP 3) cancers what to look for? Architecture Cytoplasm Nuclei Lumina Racemase + Basal cells - PSA + 5

What makes us pause to commit to a diagnosis? MOST morphologic features are NOT SPECIFIC needs a combination for our TRESHOLD Cancer Benign Crystalloids Mucin 6

What makes us pause to commit to a diagnosis? MOST morphologic features are NOT SPECIFIC needs a combination for our TRESHOLD Cancer Benign Nerve invasion 7

Features Considered Specific for Cancer (vs. Atypical glands) Circumferential NI Glomerulation Mucinous fibroplasia Extraprostatic 8

Benign Crowded Glands PIN4: Some racemase staining & patchy basal cells + Atypical architecture 9

Diffuse Atrophy Atrophic Cancer Focal Basophilic, angulated Nuclear atypia, luminal features 10

Atrophy Atrophic Cancer HMWK + (prominent basal cells) PIN4: racemase+,basal cells- 11

Postatrophic Hyperplasia (Lobular Atrophy) Atrophic duct/acini + proliferating acinar glands DX: Similar approach with simple atrophy 12

Partial Atrophy One of the most problematic Irregular or undulating, cuboidal, pale/clear 13

Partial Atrophy Cancer -/+ nucleoli, w/ complete atrophy HMWK: patchy basal cells PIN4: Racemase+, Basal cells- 14

Adenosis (Atypical Adenomatous Hyperplasia) Small glands, crystalloids, concretions Gleason pattern 1 or 2 Racemase -/weak+, basal cells patchy + 15

Adenosis (Atypical Adenomatous Hyperplasia) Usually in TURP TZ, circumscription Biopsy abrupt transition HMWK; patchy basal cells Inconspicuous nucleoli 16

Hyperplastic Pattern in Cancers Benign hyperplastic gland PIN4: racemase+, b. cells- Basal nuclei, luminal content, adjacent to usual cancer Pseudohyperplastic carcinoma Microcystic carcinoma (WHO 2016) 17

Basal Cell Hyperplasia Proliferative glands Multilayered Cancer PIN4: racemase+, bc- Multilayered, lacks atypia 18

Basal Cell Hyperplasia (Cribriform) Basal cell carcinoma Adenoid cystic-like BC hyperplasia Invasive, desmoplasia Ki-67: High (>20%) 19

Cribriform Club Central zone gland Clear cell cribriform hyperplasia Basal cell (adenoid cystic-like) hyperplasia Benign Cribriform HG PIN Atypical cribriform lesion Intermediate Intraductal carcinoma Cribriform Gleason pattern 4 carcinoma Cribriform ductal adenocarcinoma Basal cell/adenoid cystic carcinoma Cancer 20

Clear Cell Cribriform Hyperplasia Cribriform Gleason pattern 4 Lacks atypia, with basal cells IDC-P PIN4: racemase+, bc+ Florid growth 21

Nephrogenic Adenoma (Metaplasia) Intraprostatic proliferation Urethra, biphasic: papillary + glands Thick BM, cuboidal, flat, hobnail cells Infiltrative 22

Nephrogenic Adenoma (Metaplasia) PIN4: Racemase overexpression 23

Nephrogenic Adenoma (Metaplasia) PIN4: Racemase+, HMWK+ Florid growth: Fused pattern Pax8 + Fused pattern 24

Mesonephric Remnant Hyperplasia Periprostatic/bladder neck Tubules + colloid-like material Florid, fusion Lobular Infiltrativ e PSA- 25

Verumontanum Mucosal Glands Hyperplasia Urethra, ED, small glands, concretions Basal cells readily discernable PIN4: HMWK+ 26

Cowper s gland (Bulbourethral gland) Lobular Foamy Gland Carcinoma Mucinous Skeletal muscles 27

Mucinous Metaplasia Mucinous Carcinoma 28

Seminal Vesicle/Ejaculatory Duct Pleomorphism + pigments Pleomorphic giant cell carcinoma (2016 WHO) PSA/PSAP-, Pax8+ 29

Paraganglia Extraprostatic, nested, pale to amphophilic, neuroendocrine cells Vascularity 30

Xanthoma Hypernephromatoid carcinoma Foamy gland carcinoma Radiation-treated cancer CD68+ 31

Non-Specific Chronic Granulomatous Inflammation Small cell carcinoma Polymorphous cell infiltrates Synaptophysin + 32

Chronic Inflammation Individual cell (GP5) carcinoma Hormonally treated carcinoma 33

Benign Mimics in the Era of Active Surveillance To what extent should we work-up possible GP3 mimics? 1. Patient falls under criteria for AS - 3+3, <3 cores +, <50% involvement, ct2a, PSA <10 ng/ml despite having atypical focus of mimic vs. cancer. 2. Follow-up biopsy showing no apparent increase in volume and grade, including the atypical focus of mimic vs. cancer. 34

Thank you! 35